Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Banks for High Fixed Store Rates: Augment Your Investment funds- From Sea shores to Urban areas: Astonishing Worldwide Travel Objections
- Heavenly Pastry Confrontation: Pick Your #1 Sweet Treat!
- Most loved Fish Dish: What's Your Sea Pleasure?
- Taste the World: Five Food sources That Have Dazzled Worldwide Palates
- Unraveling the Specialty of Picking Your Ideal Travel Objective
- Indonesian Mega-Farm Drives Surge in Deforestation
- Russia’s New KVS Drone May Be Designed To Restore Reach In The FPV War
- 'The Boys' Season 5 premiere: How to watch for less, what to know about the final series and more
